Caliway Biopharmaceuticals Co. L
6919
Kedudukan dalam Saham
#4346
Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated... Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated to developing pharmaceuticals primarily in the fields of aesthetic medicine and chronic inflammation. Its lead investigational drug, CBL-514, is currently undergoing Phase 2 clinical trials, targeting non-surgical fat reduction, Dercum's disease, and cellulite. Beyond this, the firm is also progressing CBA-539 through preclinical exploration for potential applications in central obesity, hyperpigmentation, and skin aging. The company's offerings also extend to dietary supplements. Established in 2012, Caliway Biopharmaceuticals operates from its headquarters in New Taipei City, Taiwan.
Harga Saham
$2.29
Modal Pasaran
$3.56B
Perubahan (1 hari)
-2.50%
Perubahan (1 tahun)
-57.22%
Negara
TW
Perdagangan Caliway Biopharmaceuticals Co. L (6919)
Kategori
Healthcare
Sejarah pecahan saham untuk Caliway Biopharmaceuticals Co. L (6919)
Saham Caliway Biopharmaceuticals Co. L (simbol: 6919) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 22, 2026.
Satu saham 6919 yang dibeli sebelum Oct 22, 2026 kini bersamaan dengan 0 saham 6919.
Pecahan saham terkini berlaku pada Oct 22, 2026.
Satu saham 6919 yang dibeli sebelum Oct 22, 2026 kini bersamaan dengan 0 saham 6919.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
